Literature DB >> 7107583

Structures of the carbohydrate moieties of secretory component purified from human milk.

A Mizoguchi, T Mizuochi, A Kobata.   

Abstract

Secretory component purified from human milk contains four asparagine-linked sugar chains in one molecule. The sugar chains were released from the polypeptide portion of secretory component by hydrazinolysis as oligosaccharides and fractionated by paper electrophoresis and paper chromatography. The sugar chains of secretory component show an extraordinarily high multiplicity. By sequential exoglycosidase digestion in combination with methylation analysis, more than 40 structurally different sugar chains were found. They were all of biantennary complex type with either Man alpha 1 leads to 6(Man alpha 1 leads to 3)Man beta 1 leads to 4GlcNac beta 1 leads to 4GlcNAc or Man alpha 1 leads to 6(Man alpha 1 leads to 3)Man beta 1 leads to 4GlcNAc beta 1 leads to 4(Fuc alpha 1 leads to 6)GlcNAc as their core portions and the multiplicity is produced by variety of the two outer chain moieties. The structures of outer chains found are GlcNAc beta 1 leads to 2, +/- NeuAc alpha 2 leads to 6Gal beta 1 leads to 4GlcNAc beta 1 leads to 2, Gal beta 1 leads to 4(Fuc alpha 1 leads to 3)GlcNAc beta 1 leads to 2, GL beta 1 leads to 4GlcNAc beta 1 leads to 3Gal beta 1 leads to 4(+/- Fuc alpha 1 leads to 3)GlcNAc beta 1 leads to 2, NeuAc alpha 2 leads to 6Gal beta 1 leads to 4GlcNAc beta 1 leads to 3 Gal beta 1 leads to 4GlcNAc beta 1 leads to 2, Gal beta 1 leads to 4(Fuc alpha 1 leads to 3)GlcNAc beta 1 leads to 3Gal beta 1 leads to 4(Fuc alpha 1 leads to 3)GlcNAc beta 1 leads to 2, and NeuAc alpha 2 leads to 6Gal beta 1 leads to 4GlcNAc beta 1 leads to 3Gal beta 1 leads to 4(Fuc alpha 1 leads to 3)GlcNAc beta 1 leads to 2.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7107583

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  Antibodies in milk.

Authors:  E Telemo; L A Hanson
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-07       Impact factor: 2.673

2.  Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin.

Authors:  A E Wold; J Mestecky; M Tomana; A Kobata; H Ohbayashi; T Endo; C S Edén
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

3.  Nonspecific binding of Clostridium difficile toxin A to murine immunoglobulins occurs via the fab component.

Authors:  D L Cooke; S P Borriello
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

4.  Posttranslational processing of secretory component in the rat jejunum by a brush border metalloprotease.

Authors:  D J Ahnen; J R Singleton; T C Hoops; T M Kloppel
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

5.  Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X, and Y.

Authors:  K D Tucker; T D Wilkins
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

Review 6.  Glycan recognition at the saliva - oral microbiome interface.

Authors:  Benjamin W Cross; Stefan Ruhl
Journal:  Cell Immunol       Date:  2018-08-18       Impact factor: 4.868

7.  Secretory component in differentiating normal epithelium, benign lesions and malignancy in the human breast as monitored by monoclonal antibodies.

Authors:  J Bártek; H Tlaskalová-Hogenová; Z Stasková; J Simecková; B Vojtĕsek; A Rejthar; J Kovarík; J Bartková
Journal:  Histochemistry       Date:  1989

8.  Structural analysis of the N-glycans from human immunoglobulin A1: comparison of normal human serum immunoglobulin A1 with that isolated from patients with rheumatoid arthritis.

Authors:  M C Field; S Amatayakul-Chantler; T W Rademacher; P M Rudd; R A Dwek
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

9.  Reduced inhibition of Candida albicans adhesion by saliva from patients receiving oral cancer therapy.

Authors:  M Umazume; E Ueta; T Osaki
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

Review 10.  Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces.

Authors:  Jiri Mestecky; Michael W Russell
Journal:  Immunol Lett       Date:  2009-04-05       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.